BC
OM icon

Birchview Capital’s Outset Medical OM Stock Holding History

Birchview Capital’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-98,882
Closed -$380K – 79
2026
Q1 		$380K Sell
98,882
-31
-0% -$127 0.22% 58
2025
Q4 		$367K Buy
98,913
+20,329
+26% +$174K 0.21% 56
2025
Q3 		$1.11M Buy
78,584
+44,000
+127% +$686K 0.84% 33
2025
Q2 		$664K Buy
34,584
+10,000
+41% +$156K 0.66% 33
2025
Q1 		$272K Hold
24,584
– – 0.24% 48
2024
Q4 		$409K Buy
24,584
+23,917
+3,586% +$299K 0.33% 38
2024
Q3 		$6.77K Hold
667
– – 0.01% 60
2024
Q2 		$38.5K Buy
+667
New +$32.7K 0.04% 59

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Birchview Capital's OM Position: Q2 2026 in Review

Birchview Capital sold out of Outset Medical (OM) in Q2 2026, closing a stake of 98,882 shares — an estimated $380K sold.

Birchview Capital first reported a position in OM in Q2 2024 and held it in 8 quarters. The position peaked at $1.11M in Q3 2025. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Birchview Capital reported no remaining Outset Medical position as of Q2 2026 after selling out during the quarter.
  • Birchview Capital sold 98,882 Outset Medical shares in Q2 2026, an estimated $380K.
  • Birchview Capital first reported a position in Outset Medical in Q2 2024 and held it in 8 quarters.
  • Birchview Capital's Outset Medical position peaked at $1.11M in Q3 2025.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Birchview Capital's 13F filing for Q2 2026, filed 14 Aug 2026.